Global Comparison: Average Number of Meetings Needed to Secure New Investors Category: Health Care 2018Global Executive Teams July 19, 2019 Related Articles Actually, Private Equity Firms Have Little to Fear from Litigation by Retail Investors Michelle Celarier Premium Biopharma Specialist Cormorant Plans New $125 Million Blank-Check Venture Stephen Taub Outlook 2026: Take an Active Approach to Valuation Risk and Seek Opportunities to Diversify Sponsored by Schroders